Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT
Clinical trial NCT05623267 · RECRUITING
Trial details
- NCT number
- NCT05623267
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-01
- Primary completion
- 2025-12-31
- Enrollment
- 346
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.